Syed A. Jafry - Net Worth and Insider Trading

Syed A. Jafry Net Worth

The estimated net worth of Syed A. Jafry is at least $13 Million dollars as of 2024-04-27. Syed A. Jafry is the Sr. Vice President of Thermo Fisher Scientific Inc and owns about 21,060 shares of Thermo Fisher Scientific Inc (TMO) stock worth over $12 Million. Syed A. Jafry is also the Director of Zimmer Biomet Holdings Inc and owns about 4,060 shares of Zimmer Biomet Holdings Inc (ZBH) stock worth over $484,561. Details can be seen in Syed A. Jafry's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Syed A. Jafry has not made any transactions after 2023-11-09 and currently still holds the listed stock(s).

Transaction Summary of Syed A. Jafry

To

Syed A. Jafry Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Syed A. Jafry owns 2 companies in total, including Zimmer Biomet Holdings Inc (ZBH) , and Thermo Fisher Scientific Inc (TMO) .

Click here to see the complete history of Syed A. Jafry’s form 4 insider trades.

Insider Ownership Summary of Syed A. Jafry

Ticker Comapny Transaction Date Type of Owner
ZBH Zimmer Biomet Holdings Inc 2023-11-09 director
TMO Thermo Fisher Scientific Inc 2020-07-27 Sr. Vice President

Syed A. Jafry Latest Holdings Summary

Syed A. Jafry currently owns a total of 2 stocks. Among these stocks, Syed A. Jafry owns 21,060 shares of Thermo Fisher Scientific Inc (TMO) as of July 27, 2020, with a value of $12 Million and a weighting of 96.14%. Syed A. Jafry also owns 4,060 shares of Zimmer Biomet Holdings Inc (ZBH) as of November 9, 2023, with a value of $484,561 and a weighting of 3.86%.

Latest Holdings of Syed A. Jafry

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TMO Thermo Fisher Scientific Inc 2020-07-27 21,060 573.60 12,080,016
ZBH Zimmer Biomet Holdings Inc 2023-11-09 4,060 119.35 484,561

Holding Weightings of Syed A. Jafry


Syed A. Jafry Form 4 Trading Tracker

According to the SEC Form 4 filings, Syed A. Jafry has made a total of 1 transactions in Thermo Fisher Scientific Inc (TMO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Thermo Fisher Scientific Inc is the sale of 20,513 shares on July 27, 2020, which brought Syed A. Jafry around $9 Million.

According to the SEC Form 4 filings, Syed A. Jafry has made a total of 1 transactions in Zimmer Biomet Holdings Inc (ZBH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Zimmer Biomet Holdings Inc is the acquisition of 2,135 shares on November 9, 2023, which cost Syed A. Jafry around $223,641.

Insider Trading History of Syed A. Jafry

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Syed A. Jafry Trading Performance

GuruFocus tracks the stock performance after each of Syed A. Jafry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Syed A. Jafry is 4.4%. GuruFocus also compares Syed A. Jafry's trading performance to market benchmark return within the same time period. The performance of stocks bought by Syed A. Jafry within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Syed A. Jafry's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Syed A. Jafry

Average Return

8.56%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.27 4.4 11 8.56 14.13 0.67
Relative Return to S&P 500(%) 3.18 -2.5 6.62 3.19 -3.81 -14.69

Syed A. Jafry Ownership Network

Ownership Network List of Syed A. Jafry

No Data

Ownership Network Relation of Syed A. Jafry


Syed A. Jafry Owned Company Details

What does Zimmer Biomet Holdings Inc do?

Who are the key executives at Zimmer Biomet Holdings Inc?

Syed A. Jafry is the director of Zimmer Biomet Holdings Inc. Other key executives at Zimmer Biomet Holdings Inc include President & Asia Pacific Sang Yi , Assoc. Gen. Counsel & Corp. Sec Chad F Phipps , and Pres & Europe & M. East & Africa Zuilen Wilfred Van .

Zimmer Biomet Holdings Inc (ZBH) Insider Trades Summary

Over the past 18 months, Syed A. Jafry made 1 insider transaction in Zimmer Biomet Holdings Inc (ZBH) with a net purchase of 2,135. Other recent insider transactions involving Zimmer Biomet Holdings Inc (ZBH) include a net sale of 60,723 shares made by Chad F Phipps , a net purchase of 2,000 shares made by Robert Hagemann , and a net sale of 1,705 shares made by Sang Yi .

In summary, during the past 3 months, insiders sold 27,861 shares of Zimmer Biomet Holdings Inc (ZBH) in total and bought 0 shares, with a net sale of 27,861 shares. During the past 18 months, 62,428 shares of Zimmer Biomet Holdings Inc (ZBH) were sold and 9,456 shares were bought by its insiders, resulting in a net sale of 52,972 shares.

Zimmer Biomet Holdings Inc (ZBH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zimmer Biomet Holdings Inc Insider Transactions

No Available Data

Syed A. Jafry Mailing Address

Above is the net worth, insider trading, and ownership report for Syed A. Jafry. You might contact Syed A. Jafry via mailing address: 345 E. Main Street, Warsaw In 46580.

Discussions on Syed A. Jafry

No discussions yet.